Accel

True Anomaly is a company dedicated to advancing space security and resilience through an integrated approach that combines spacecraft, software, and autonomy. It aims to create a secure, stable, and sustainable space environment for the United States, its allies, and partners. The company designs, builds, and sells innovative solutions that address the complexities of space security. By leveraging advanced spacecraft manufacturing infrastructure and autonomy systems, True Anomaly revolutionizes how space missions are conducted, while also offering training and simulation tools. Its focus on providing comprehensive software solutions positions True Anomaly as a key player in the evolving commercial space market.

Turbine Ltd, established in 2015 and headquartered in Budapest, Hungary, specializes in computational biology for cancer drug development. The company's core product is a predictive model that simulates cellular behavior, aiding in the discovery, preclinical testing, and development of cancer therapies. Turbine's platform leverages proprietary Simulated Cell technology and artificial intelligence to identify novel protein targets and precision biomarkers, ultimately enhancing the translation of research into effective patient treatments.

Turbine Ltd, established in 2015 and headquartered in Budapest, Hungary, specializes in computational biology for cancer drug development. The company's core product is a predictive model that simulates cellular behavior, aiding in the discovery, preclinical testing, and development of cancer therapies. Turbine's platform leverages proprietary Simulated Cell technology and artificial intelligence to identify novel protein targets and precision biomarkers, ultimately enhancing the translation of research into effective patient treatments.